Norway
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 22.08 M
|
Dec. 31, 2023 | USD 0.73 | 3.02% |
|
Norway |
|
2 |
USD 8.17 M
|
Dec. 31, 2023 | USD 2.21 | -0.65% |
|
Norway |
|
3 |
USD 3.72 M
|
Dec. 31, 2023 | USD 1.13 | -2.55% |
|
Norway |
|
4 |
USD -32.59
|
Dec. 31, 2023 | USD 0.23 | 0.55% |
|
Norway |
|
5 |
USD -194.52 K
|
Dec. 31, 2024 | USD 0.19 | -0.80% |
|
Norway |
|
6 |
USD -451.41 K
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
|
7 |
USD -5.53 M
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
The Pharmaceuticals company in Norway with the highest Net Cash Used Provided By Financing Activities is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at USD 22.08 M.
The Pharmaceuticals company in Norway with the lowest Net Cash Used Provided By Financing Activities is Photocure ASA (Oslo Stock Exchange: PHO.OL) at USD -5.53 M.
The top 10 Pharmaceuticals companies in Norway by Net Cash Used Provided By Financing Activities are BerGenBio ASA, Navamedic ASA, Lifecare AS, Thor Medical ASA, Ultimovacs ASA, Gentian Diagnostics ASA and Photocure ASA.
The bottom 10 Pharmaceuticals companies in Norway by Net Cash Used Provided By Financing Activities are Photocure ASA, Gentian Diagnostics ASA, Ultimovacs ASA, Thor Medical ASA, Lifecare AS, Navamedic ASA and BerGenBio ASA.